JustPaste.it

Spotlight Speaker: Dr. Zahraa Khalifa on Shaping the Future of Drug Development

drzahraakhalifaclinicaltrialsanddrugdeliveryconference.png

Speech Title: Artificial Intelligence Across the Drug Discovery Pipeline: From Molecule to Market


Introduction

The 17th Global Digital Pharma, Clinical Trials & Drug Delivery Conference is proud to spotlight Dr. Zahraa Khalifa, a distinguished researcher and educator shaping the next era of pharmaceutical innovation. Her upcoming presentation, “Artificial Intelligence Across the Drug Discovery Pipeline: From Molecule to Market,” will explore how AI-driven technologies are revolutionizing every stage of drug development—from molecular design to regulatory approval.

As the pharmaceutical landscape rapidly evolves, Dr. Khalifa’s insights bridge the gap between traditional drug delivery systems and cutting-edge digital solutions, highlighting the transformative role of AI in accelerating research and improving patient outcomes.


Biography

Dr. Zahraa Khalifa completed her PhD in Pharmaceutical Sciences (Drug Delivery) from the University of Strathclyde, UK, one of the world’s leading institutions in pharmaceutical education. She currently serves as a Lecturer in the Department of Pharmaceutical Sciences at Dubai Medical University.

With over a decade of experience in teaching, research, and academic leadership, Dr. Khalifa has established herself as an authority in drug delivery systems and advanced formulation technologies. Her research is widely published in Scopus-indexed journals, reflecting her dedication to pushing the boundaries of pharmaceutical science.

Dr. Khalifa also holds a Postgraduate Certificate in Artificial Intelligence in Drug Discovery from the London School of International Business, emphasizing her commitment to integrating digital intelligence into drug innovation.


Affiliation

Lecturer, Pharmaceutical Sciences (Drug Delivery)
Dubai Medical University, UAE


Research Interests

  • Advanced Drug Delivery Systems
  • Artificial Intelligence in Drug Discovery
  • Nanomedicine and Targeted Therapy
  • Pharmaceutical Formulation Development
  • Translational Research in Drug Development

Awards, Recognitions & Achievements

  • PhD Scholarship Awardee, University of Strathclyde, UK
  • Recipient of multiple Best Research Paper Awards in international pharmaceutical conferences
  • Author of numerous peer-reviewed and Scopus-indexed publications
  • Recognized for contributions to pharmaceutical education and curriculum innovation in the UAE

Benefits of Attending Dr. Zahraa Khalifa’s Session

  • Gain valuable insights into how AI transforms each phase of the drug discovery pipeline.
  • Learn how data-driven innovation can reduce costs, shorten timelines, and improve drug efficacy.
  • Understand the integration of AI and machine learning in formulation design, preclinical testing, and market strategies.
  • Network with top professionals and researchers advancing digital pharma and clinical innovations.
  • Get inspired by real-world examples of AI applications from molecule design to patient delivery.

Join Us at the Conference

Don’t miss the opportunity to hear Dr. Zahraa Khalifa and other global experts share their groundbreaking work at the 17th Global Digital Pharma, Clinical Trials & Drug Delivery Conference, taking place December 17–19, 2025, At Novotel Dubai Al Barsha Sheikh Zayed Rd - opp. Insurance Market Metro Station - UAE

Kindly submit your Abstract: https://pharmacy.utilitarianconferences.com/submit-abstract

Kindly Register now: https://pharmacy.utilitarianconferences.com/registration
To know more: https://pharmacy.utilitarianconferences.com/

Contact Us:
WhatsApp: +971551792927
info-ucg@utilitarianconferences.com
*pharmaceutical@ucgconferences.com


Conclusion
Dr. Zahraa Khalifa embodies the spirit of innovation driving the future of pharmaceutical science. Through her expertise in drug delivery and her visionary approach to AI in drug discovery, she continues to inspire researchers, students, and professionals worldwide. Her participation in this conference reaffirms the commitment of modern science to bridge technology and human health for a smarter, faster, and more effective drug development ecosystem.


#PharmaUCG #GlobalDigitalPharma2025 #PharmaInnovation #DrugDiscovery #ArtificialIntelligence #ClinicalTrials #DrugDelivery #DigitalPharma #PharmaConference #AIinPharma #PharmaceuticalSciences #DubaiConference #PharmaResearch #UtilitarianConferences #ZahraaKhalifa #FutureofDrugDevelopmen